Ataxia Global Clinical Trials Review, H1, 2014 - FOX Carolina 21

Ataxia Global Clinical Trials Review, H1, 2014

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, June 17, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Ataxia Global Clinical Trials Review, H1, 2014

http://www.reportlinker.com/p02160167/Ataxia-Global-Clinical-Trials-Review-H1-2014.html

Ataxia Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Ataxia Global Clinical Trials Review, H1, 2014" provides data on the Ataxia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ataxia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ataxia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

List of Tables
3

List of Figures
4
Introduction 5
Ataxia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Ataxia to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Ataxia to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22

Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Ataxia Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
GlaxoSmithKline plc 28
Clinical Trial Overview of GlaxoSmithKline plc 28
Shenzhen Beike Biotechnology Co., Ltd. 29
Clinical Trial Overview of Shenzhen Beike Biotechnology Co., Ltd. 29
Clinical Trial Overview of Top Institutes / Government 30
National Institute of Neurological Disorders and Stroke 30
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 30
Office of Rare Diseases, National Institutes of Health 31
Clinical Trial Overview of Office of Rare Diseases, National Institutes of Health 31
S. Andrea Hospital Sapienza Rome University 32
Clinical Trial Overview of S. Andrea Hospital Sapienza Rome University 32
Fundacion Para La Investigacion Biomedica Del Hospital Universitarios La Paz 33
Clinical Trial Overview of Fundacion Para La Investigacion Biomedica Del Hospital Universitarios La Paz 33
General Hospital of Chinese Armed Police Forces 34
Clinical Trial Overview of General Hospital of Chinese Armed Police Forces 34
Columbia University 35

Clinical Trial Overview of Columbia University 35
Seattle Children's Hospital, Research and Foundation 36
Clinical Trial Overview of Seattle Children's Hospital, Research and Foundation 36
University of California, Los Angeles 37
Clinical Trial Overview of University of California, Los Angeles 37
McMaster University 38
Clinical Trial Overview of McMaster University 38
The Sheba Medical Center 39
Clinical Trial Overview of The Sheba Medical Center 39
Five Key Clinical Profiles 40
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 72

List of Tables

Ataxia Therapeutics, Global, Clinical Trials by Region, 2014* 6
Ataxia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Ataxia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Ataxia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Ataxia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Ataxia Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Ataxia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 12
Proportion of Ataxia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Ataxia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Ataxia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Ataxia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Ataxia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Ataxia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Ataxia Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Ataxia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Ataxia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Ataxia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Ataxia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Ataxia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Ataxia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Ataxia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Ataxia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 28
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenzhen Beike

Biotechnology Co., Ltd., 2014* 29
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 30
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Office of Rare Diseases, National Institutes of Health, 2014* 31
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by S. Andrea Hospital Sapienza Rome University, 2014* 32
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion Para La Investigacion Biomedica Del Hospital Universitarios La Paz, 2014* 33
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by General Hospital of Chinese Armed Police Forces, 2014* 34
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2014* 35
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, Research and Foundation, 2014* 36
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 37
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2014* 38
Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014* 39

List of Figures

Ataxia Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Ataxia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Ataxia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Ataxia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Ataxia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Ataxia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Ataxia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 12
Proportion of Ataxia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Ataxia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Ataxia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Ataxia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Ataxia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Ataxia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Ataxia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Ataxia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Ataxia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Ataxia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Ataxia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Ataxia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Ataxia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Ataxia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Ataxia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 71

To order this report: Ataxia Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p02160167/Ataxia-Global-Clinical-Trials-Review-H1-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
Fox Carolina
Powered by WorldNow CNN
All content © 2014, WHNS; Greenville, SC. (A Meredith Corporation Station) and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.